Can I switch from semaglutide to tirzepatide if I plateau
22.Perkovic V, Tuttle KR, Rossing P, et al
Tucson Wellness MD provides baseline lab work and cardiovascular assessment before starting, a structured titration schedule with regular follow-up, monitoring of weight loss velocity and side effect profile, and adjustment of dosing based on individual response
It was approved by the FDA in 2004
In the third sensitivity analysis, adherence rates for both drugs were high with MPR (95% CI) at 102 (98114)% for DPP-4i and 82 (73106)% for GLP-1a, respectively
Renal and hepatic function may be relevant to dosing in any future approved formulation, but no specific guidance exists for retatrutide at this stage